I remember RSV from when my tykes were in their toddler days, one of the bad acronyms we didn’t want them to get. It’s good to know there’s work taking place at UTMB that might alleviate this concern for future kids and their parents.
New treatment approach holds promise for children infected by dangerous respiratory virus
EurekAlert, Oct. 17
When a child under the age of 2 contracts a respiratory tract infection requiring hospitalization, odds are that the cause is respiratory syncytial virus (RSV). One of the world’s most common and dangerous early-childhood infections, RSV puts more than 100,000 children a year in the hospital in the U.S. alone; the infection may also increase the chances that a child will develop asthma. Currently, neither a safe vaccine nor an effective therapy for RSV exists. Now, however, University of Texas Medical Branch at Galveston (UTMB) researchers have taken an important step toward developing a therapy for RSV. Read more…